Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Aukje C. Bos"'
Effect of Inspiratory Maneuvers on Lung Deposition of Tobramycin Inhalation Powder: A Modeling Study
Autor:
Aukje C. Bos, Eleni-Rosalina Andrinopoulou, Jennifer J. Meerburg, Marcel van Straten, Hwain Shin, Kamal Hamed, Paul Mastoridis, Harm A.W.M. Tiddens
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 33(2), 61-72. Mary Ann Liebert Inc.
Background: Tobramycin inhalation powder (TIP) and tobramycin inhalation solution (TIS) are considered equally effective for the treatment of chronic pulmonary Pseudomonas aeruginosa infection in cystic fibrosis (CF) patients. The impact of TIP inhal
Autor:
Harm A.W.M. Tiddens, Hettie M. Janssens, Els C. van der Wiel, Aukje C. Bos, Ilaria Meneghelli, Sonia Volpi, Beatrice Guidetti, Menno M. van der Eerden
Publikováno v:
Paediatric cystic fibrosis (CF).
Autor:
Aukje C Bos, Cedric van Holsbeke, Jan W de Backer, Mireille van Westreenen, Hettie M Janssens, Wim G Vos, Harm A W M Tiddens
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0118454 (2015)
Pseudomonas aeruginosa (Pa) infection is an important contributor to the progression of cystic fibrosis (CF) lung disease. The cornerstone treatment for Pa infection is the use of inhaled antibiotics. However, there is substantial lung disease hetero
Externí odkaz:
https://doaj.org/article/837e7213df304b80af58af2166c11ccd
Autor:
Mireille van Westreenen, Hettie M. Janssens, Aukje C. Bos, Johan W. Mouton, Harm A.W.M. Tiddens, Eleni-Rosalina Andrinopoulou
Publikováno v:
Journal of Antimicrobial Chemotherapy, 72(12), 3435-3442. Oxford University Press
__Background:__ Inhaled tobramycin is important in the treatment of Pseudomonas aeruginosa (Pa) infections in cystic fibrosis (CF). However, despite its use it fails to attenuate the clinical progression of CF lung disease. The bactericidal efficacy
Publikováno v:
Journal of Cystic Fibrosis, 16, 1, pp. 13-23
Journal of Cystic Fibrosis, 16(1), 13-23. Elsevier
Journal of Cystic Fibrosis, 16, 13-23
Journal of Cystic Fibrosis, 16(1), 13-23. Elsevier
Journal of Cystic Fibrosis, 16, 13-23
Background Chronic airway infections in patients with cystic fibrosis (CF) are most often treated with inhaled antibiotics of which deposition patterns have been extensively studied. However, the journey of aerosol particles does not end after deposi
Autor:
Annelies E. Kok, Aukje C. Bos, Harm A.W.M. Tiddens, Hettie M. Janssens, Eleni-Rosalina Andrinopoulou, Kirby Tong Minh, Inge Heeres, Joke L. Overweel-Uijterlinde
Publikováno v:
Journal of Cystic Fibrosis, 15(5), 645-651. Elsevier
Background Cystic fibrosis (CF) caregivers focus on correct inhalation technique for nebulisers as this is essential to optimize efficacy of inhaled drugs. However, little is known on this nebuliser technique of patients at home. Methods Three "hidde
Autor:
Aukje C. Bos, Daan J Touw, Hettie M. Janssens, Harry G.M. Heijerman, A.J. Van Velzen, Harm A.W.M. Tiddens
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 29(3), 273-280. Mary Ann Liebert Inc.
Journal of aerosol medicine and pulmonary drug delivery, 29(3), 273-280. MARY ANN LIEBERT, INC
Journal of aerosol medicine and pulmonary drug delivery, 29(3), 273-280. MARY ANN LIEBERT, INC
Background: Better treatment outcomes in cystic fibrosis (CF) may be expected by changing standard twice daily (BID) tobramycin inhalation with the conventional nebulizer to once daily (OD) inhalation at double the standard BID dose with a controlled
Autor:
Aukje C. Bos, Els C. van der Wiel, Karla Gonzalez-Graniel, Leonie A. Tepper, Harm A.W.M. Tiddens, Hugo J. Duivenvoorden, Elisabeth M. W. J. Utens, Alexandra L. Quittner, Daan Caudri
Publikováno v:
European Respiratory Journal, 42, 371-379. European Respiratory Society
European respiratory journal, 42(2), 371-379. European Respiratory Society
European respiratory journal, 42(2), 371-379. European Respiratory Society
Cystic fibrosis (CF) is primarily characterised by bronchiectasis and trapped air on chest computed tomography (CT). The revised Cystic Fibrosis Questionnaire respiratory symptoms scale (CFQ-R RSS) measures health-related quality of life. To validate